B. Riley FBR likes Intercept, NASH players Viking, Galmed

Intercept Pharmaceuticals (NASDAQ:ICPT) initiated with Buy rating and $155 (48% upside) price target at B. Riley FBR.

Viking Therapeutics (NASDAQ:VKTX) initiated with Buy rating and $16 (69% upside) price target at B. Riley FBR citing upside with lead drug VK2809 in NASH.

Galmed Pharmaceuticals (NASDAQ:GLMD) initiated with Buy rating and $28 (254% upside) price target at B. Riley FBR citing rosy prospects for Aramchol in NASH.

https://seekingalpha.com/news/3416356-b-riley-fbr-likes-nash-players-viking-therapeutics-galmed-pharma-premarket-analyst-action